Express News | Bio-techne Announced Its Participation In Spear Bio's $45M Series A Funding Round, Spear Bio Will Use The Proceeds To Further Accelerate Product Development And Scale Its In-house Manufacturing Capacity
Express News | Bio-Techne Corp - Participates in Spear Bio's $45M Series a Funding
Express News | Bio-Techne Announces Strategic Investment in Spear Bio
10 Health Care Stocks Whale Activity In Today's Session
What to Expect From Bio-Techne's Next Quarterly Earnings Report
Bio-Techne Corporation's (NASDAQ:TECH) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Express News | Bio-Techne Corp : Leerink Partners Cuts Target Price to $90 From $95
BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS
Welcome to the Everything Rally. How Stock Investors Can Play It.
These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird
This Bio-Techne Insider Reduced Their Stake By 19%
KeyBanc Maintains Bio-Techne(TECH.US) With Buy Rating, Maintains Target Price $80
Declining Stock and Decent Financials: Is The Market Wrong About Bio-Techne Corporation (NASDAQ:TECH)?
Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)?
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
Express News | Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to Serve as Independent Chairman of the Board of Directors
Express News | Scaleready Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (Cgt) Development and Manufacturing
Bio-Techne's (NASDAQ:TECH) Investors Will Be Pleased With Their Notable 69% Return Over the Last Five Years
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
Citi Downgrades Bio-Techne(TECH.US) to Hold Rating, Raises Target Price to $85